These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9214478)

  • 1. Early primary biliary cirrhosis: just delayed or different?
    Lindor KD
    Hepatology; 1997 Jul; 26(1):239-41. PubMed ID: 9214478
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary biliary cirrhosis: when and why does the disease develop?
    Floreani A; Ostuni PA; Ferrara F; Guido M
    Dig Liver Dis; 2006 Apr; 38(4):272-5. PubMed ID: 16567309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary biliary cirrhosis--antimitochondrial antibody and the reactive antigens].
    Ishibashi H
    Fukuoka Igaku Zasshi; 1995 Oct; 86(10):385-8. PubMed ID: 8529992
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
    Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
    Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary biliary cirrhosis].
    Aizawa Y; Toda G
    Ryoikibetsu Shokogun Shirizu; 2000; (31):218-21. PubMed ID: 11269062
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection and clinical significance of serum antimitochondrial antibody in patients with viral hepatitis or primary biliary cirrhosis].
    Lu J; Deng L; Li G; Yao C; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):220. PubMed ID: 12113685
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoantibodies in primary biliary cirrhosis: antimitochondrial autoantibodies.
    Chantran Y; Ballot É; Johanet C
    Clin Res Hepatol Gastroenterol; 2013 Sep; 37(4):431-3. PubMed ID: 23773485
    [No Abstract]   [Full Text] [Related]  

  • 8. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis.
    Dimoulios P; Kolios G; Notas G; Matrella E; Xidakis C; Koulentaki M; Tsagarakis N; Kouroumalis A; Kouroumalis E
    Aliment Pharmacol Ther; 2005 Feb; 21(3):227-34. PubMed ID: 15691296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is prevalence of PBC underestimated in patients with systemic sclerosis?
    Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
    Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ursodeoxycholic acid in the treatment of primary biliary liver cirrhosis].
    Poupon R
    Gastroenterol Clin Biol; 1994; 18(2 Pt 3):T5-8. PubMed ID: 8045357
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune hemolysis associated with primary biliary cirrhosis responding to ursodeoxycholic acid as sole treatment.
    Fuller SJ; Kumar P; Weltman M; Wiley JS
    Am J Hematol; 2003 Jan; 72(1):31-3. PubMed ID: 12508265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubulointerstitial nephritis and Fanconi syndrome in primary biliary cirrhosis.
    Lino M; Binaut R; Noël LH; Patey N; Rustin P; Daniel L; Serpaggi J; Varaut A; Vanhille P; Knebelmann B; Grünfeld JP; Fakhouri F
    Am J Kidney Dis; 2005 Sep; 46(3):e41-6. PubMed ID: 16129198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?
    Joshi S; Cauch-Dudek K; Heathcote EJ; Lindor K; Jorgensen R; Klein R
    Am J Gastroenterol; 2002 Apr; 97(4):999-1002. PubMed ID: 12003438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial granulomatous dermatitis associated with primary biliary cirrhosis.
    Wang Y; Wu Y; Zheng Z; Bai Y; Cui Y
    J Dermatol; 2018 Jan; 45(1):112-113. PubMed ID: 28225148
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary biliary cirrhosis. Immunological aggression and aggression by biliary acids].
    Poupon R
    Rev Prat; 1994 May; 44(10):1325-8. PubMed ID: 7939192
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophils and primary biliary cirrhosis-stoking the fire?
    Neuberger J
    Hepatology; 1999 Jul; 30(1):335-7. PubMed ID: 10385676
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bronchiolitis obliterans with organizing pneumonia and primary biliary cirrhosis].
    Montero C; Brage A; Rodríguez-Trigo G; Verea H
    Med Clin (Barc); 2003 Jan; 120(1):37-8. PubMed ID: 12525305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.